U.S. RESEARCH ROUNDUP-Definium Therapeutics, Kenvue, Werner Enterprises

Reuters
2026.01.30 07:45
portai
I'm PortAI, I can summarize articles.

Wall Street analysts have revised ratings and price targets for several U.S.-listed companies. Notable changes include Jefferies initiating coverage of Definium Therapeutics with a buy rating and a target price of $30, while Kenvue was downgraded to hold with a target price cut to $18. Other companies like Ameriprise Financial and United Rentals also saw target price adjustments. Overall, analysts are actively reassessing their positions on various stocks, reflecting changing market conditions.